Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02853097 · ClinicalTrials.gov registry record
Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer Patients
A clinical trial, sponsored by University of Southern California.
- Terminated
- Registry status
- 7
- Enrollment target
NCT02853097 is a clinical trial that was terminated before completion, run by University of Southern California. The registered enrollment target is 7 participants.
The verdict
NCT02853097 was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
This research trial studies cell-free deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in blood from patients with prostate cancer that does not respond to hormone therapy and has spread to other places in the body. Studying samples of blood from patients with prostate cancer may help doctors to learn more about the changes that occur in tumor cells over time and how they become resistant to anti-cancer drugs.
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Cytology Specimen Collection Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-06-14 |
| Est. Completion | 2020-09-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02853097
The ClinicalTrials.gov registry entry for NCT02853097 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT02853097 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02853097 about?
NCT02853097 is a clinical study titled "Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer Patients". This research trial studies cell-free deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in blood from patients with prostate cancer that does not respond to hormone therapy and has spread to other places in the body. Studying samples of blood from patients with prostate cancer may help doctors ...
What is the current status of trial NCT02853097?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2016-06-14. Estimated completion is 2020-09-27.
What interventions are being tested in trial NCT02853097?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Cytology Specimen Collection Procedure (OTHER).
Who is sponsoring clinical trial NCT02853097?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.